(Q54659236)

2 June 2018

reason for preferred rank

title

Modulation of the development of human monocyte‐derived dendritic cells by lithium chloride (English)

1 reference

13 June 2024

Modulation of the development of human monocyte-derived dendritic cells by lithium chloride (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20672290

13 June 2024

1 reference

8

Ming-Chyi Huang

1 reference

2 June 2018

author name string

Ko-Jiunn Liu

1

1 reference

2 June 2018

Yueh-Lun Lee

2

1 reference

2 June 2018

Yi-Yuan Yang

3

1 reference

2 June 2018

Neng-Yao Shih

4

1 reference

2 June 2018

Chia-Chen Ho

5

1 reference

2 June 2018

Yu-Chen Wu

6

1 reference

2 June 2018

Tze-Sing Huang

7

1 reference

2 June 2018

Hsing-Cheng Liu

9

1 reference

2 June 2018

Sy-Jye Leu

11

1 reference

2 June 2018

Winston W. Shen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20672290

13 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20672290

13 June 2024

publication date

1 February 2011

1 reference

2 June 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcp.22348

1 reference

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.22348

13 June 2024

1 reference

Journal of Cellular Physiology

13 June 2024

published in

1 reference

2 June 2018

volume

226

1 reference

2 June 2018

issue

2

1 reference

2 June 2018

page(s)

424-433

1 reference

2 June 2018

Lithium prevents and ameliorates experimental autoimmune encephalomyelitis

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FJCP.22348

Peroxisome Proliferator-Activated Receptor-gamma Is a Potent Target for Prevention and Treatment in Human Prostate and Testicular Cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FJCP.22348

Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FJCP.22348

Dendritic cells and the control of immunity

21 January 2018

1

1 reference

Immunobiology of dendritic cells

13 June 2024

2

1 reference

CD1b is expressed in multiple sclerosis lesions

13 June 2024

3

1 reference

Cytokine production in bipolar affective disorder patients under lithium treatment

13 June 2024

4

1 reference

High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder

13 June 2024

5

1 reference

Antigen presentation by CD1 molecules and the generation of lipid-specific T cell immunity

13 June 2024

6

1 reference

A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder

13 June 2024

7

1 reference

Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons

13 June 2024

8

1 reference

Implication of serum concentration monitoring in patients with lithium intoxication

13 June 2024

9

1 reference

Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?

13 June 2024

10

1 reference

Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium

13 June 2024

12

1 reference

Lithium chloride increases the production of amyloid-beta peptide independently from its inhibition of glycogen synthase kinase 3.

13 June 2024

14

1 reference

Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers

13 June 2024

15

1 reference

Dendritic Cell Function in Vivo during the Steady State: A Role in Peripheral Tolerance

13 June 2024

16

1 reference

Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes

13 June 2024

17

1 reference

The distribution of CD1 molecules in inflammatory neuropathy

13 June 2024

18

1 reference

Mesenchymal progenitor cells in the human umbilical cord.

13 June 2024

19

1 reference

T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients

13 June 2024

20

1 reference

Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder.

13 June 2024

21

1 reference

A molecular mechanism for the effect of lithium on development

13 June 2024

22

1 reference

Monocyte-derived dendritic cells in bipolar disorder

13 June 2024

23

1 reference

Chronic lithium treatment antagonizes glutamate-induced decrease of phosphorylated CREB in neurons via reducing protein phosphatase 1 and increasing MEK activities

13 June 2024

24

1 reference

High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure.

13 June 2024

25

1 reference

Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial

13 June 2024

26

1 reference

Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adip

13 June 2024

28

1 reference

Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations.

13 June 2024

29

1 reference

Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3.

13 June 2024

30

1 reference

Lithium neurotoxicity at normal therapeutic levels

13 June 2024

32

1 reference

Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons.

13 June 2024

33

1 reference

Acute lithium intoxication

13 June 2024

34

1 reference

Immune variations in bipolar disorder: phasic differences

13 June 2024

35

1 reference

Dendritic cells: a link between innate and adaptive immunity

13 June 2024

36

1 reference

Linking innate and adaptive immunity

13 June 2024

37

1 reference

Drug research: the ups and downs of lithium

13 June 2024

38

1 reference

Lithium in the treatment of mood disorders

13 June 2024

39

1 reference

Modulating the immune response with dendritic cells and their growth factors

13 June 2024

40

1 reference

GSK-3 mediates differentiation and activation of proinflammatory dendritic cells

13 June 2024

41

1 reference

Lithium neuroprotection: molecular mechanisms and clinical implications

13 June 2024

43

1 reference

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

13 June 2024

44

1 reference

Severe lithium toxicity with "normal" serum concentrations

13 June 2024

46

1 reference

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

13 June 2024

47

1 reference

Activation of PPARγ Specifies a Dendritic Cell Subtype Capable of Enhanced Induction of iNKT Cell Expansion

13 June 2024

48

1 reference

PPAR regulates the function of human dendritic cells primarily by altering lipid metabolism

13 June 2024

49

1 reference

Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma

13 June 2024

50

1 reference

Activation of indices of cell-mediated immunity in bipolar mania

13 June 2024

51

1 reference

Novel anti-inflammatory role for glycogen synthase kinase-3beta in the inhibition of tumor necrosis factor-alpha- and interleukin-1beta-induced inflammatory gene expression

13 June 2024

52

1 reference

Lithium levels and toxicity among hospitalized patients

13 June 2024

53

1 reference

Critical roles of Raf/MEK/ERK and PI3K/AKT signaling and inactivation of p38 MAP kinase in the differentiation and survival of monocyte-derived immature dendritic cells

13 June 2024

54

1 reference

CD1 mediated T cell recognition of glycolipids

13 June 2024

55

1 reference

Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3.

13 June 2024

56

1 reference

13 June 2024

Identifiers

DOI

10.1002/JCP.22348

1 reference

2 June 2018

release_xb5wry7uebgd3knuav7y7exjwe

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xb5wry7uebgd3knuav7y7exjwe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

2 June 2018